Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for … DA Calhoun, D Jones, S Textor, DC Goff, TP Murphy, RD Toto, A White, ... Hypertension 51 (6), 1403-1419, 2008 | 4035 | 2008 |
Alogliptin after acute coronary syndrome in patients with type 2 diabetes WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ... New England journal of medicine 369 (14), 1327-1335, 2013 | 3174 | 2013 |
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension MA Weber, EL Schiffrin, WB White, S Mann, LH Lindholm, JG Kenerson, ... Journal of hypertension 32 (1), 3-15, 2014 | 2489 | 2014 |
Measurement of blood pressure in humans: a scientific statement from the American Heart Association P Muntner, D Shimbo, RM Carey, JB Charleston, T Gaillard, S Misra, ... Hypertension 73 (5), e35-e66, 2019 | 1340 | 2019 |
Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association RM Carey, DA Calhoun, GL Bakris, RD Brook, SL Daugherty, ... Hypertension 72 (5), e53-e90, 2018 | 1063* | 2018 |
Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial HR Black, WJ Elliott, G Grandits, P Grambsch, T Lucente, WB White, ... Jama 289 (16), 2073-2082, 2003 | 998 | 2003 |
Cardiovascular safety of febuxostat or allopurinol in patients with gout WB White, KG Saag, MA Becker, JS Borer, PB Gorelick, A Whelton, ... New England Journal of Medicine 378 (13), 1200-1210, 2018 | 923 | 2018 |
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial F Zannad, CP Cannon, WC Cushman, GL Bakris, V Menon, AT Perez, ... The Lancet 385 (9982), 2067-2076, 2015 | 896 | 2015 |
A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study Parkinson Study Group Archives of Neurology 59 (12), 1937-1943, 2002 | 700 | 2002 |
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials JS Sundy, HSB Baraf, RA Yood, NL Edwards, SR Gutierrez-Urena, ... Jama 306 (7), 711-720, 2011 | 697 | 2011 |
Interpretation of the vibrational spectra of spinels WB White, BA DeAngelis Spectrochimica Acta Part A: Molecular Spectroscopy 23 (4), 985-995, 1967 | 669 | 1967 |
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American … C Rosendorff, DT Lackland, M Allison, WS Aronow, HR Black, ... Circulation 131 (19), e435-e470, 2015 | 601* | 2015 |
Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension WB White, P Schulman, EJ McCabe, HM Dey Jama 261 (6), 873-877, 1989 | 533 | 1989 |
Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension WB White, HM Dey, P Schulman American heart journal 118 (4), 782-795, 1989 | 522 | 1989 |
Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis WL Baker, LR Smyth, DM Riche, EM Bourret, KW Chamberlin, WB White Journal of the American Society of Hypertension 8 (4), 262-275. e9, 2014 | 507 | 2014 |
National standard for measurement of resting and ambulatory blood pressures with automated sphygmomanometers. WB White, AS Berson, C Robbins, MJ Jamieson, LM Prisant, E Roccella, ... Hypertension 21 (4), 504-509, 1993 | 500 | 1993 |
The carbonate minerals WB White | 491 | 1974 |
Effects of celecoxib and rofecoxib on blood pressure and edema in patients≥ 65 years of age with systemic hypertension and osteoarthritis A Whelton, WB White, AE Bello, JA Puma, JG Fort, SVII Investigators The American journal of cardiology 90 (9), 959-963, 2002 | 421 | 2002 |
Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension WB White, D Duprez, R St Hillaire, S Krause, B Roniker, J Kuse-Hamilton, ... Hypertension 41 (5), 1021-1026, 2003 | 394 | 2003 |
Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac WB White, G Faich, A Whelton, C Maurath, NJ Ridge, KM Verburg, ... The American journal of cardiology 89 (4), 425-430, 2002 | 352 | 2002 |